Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UPSTREAM: Tezspire in asthma
NCT02698501Phase 2Completed
- Start
- Aug 2016
- Primary completion
- Aug 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tezepelumab in asthma. Started Aug 2016; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02698501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02698501.